BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10206983)

  • 21. Discordance between the binding affinity of mitogen-activated protein kinase subfamily members for MAP kinase phosphatase-2 and their ability to activate the phosphatase catalytically.
    Chen P; Hutter D; Yang X; Gorospe M; Davis RJ; Liu Y
    J Biol Chem; 2001 Aug; 276(31):29440-9. PubMed ID: 11387337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation.
    Alonso A; Saxena M; Williams S; Mustelin T
    J Biol Chem; 2001 Feb; 276(7):4766-71. PubMed ID: 11085983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6.
    Marti F; Krause A; Post NH; Lyddane C; Dupont B; Sadelain M; King PD
    J Immunol; 2001 Jan; 166(1):197-206. PubMed ID: 11123293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B.
    Budagian V; Bulanova E; Brovko L; Orinska Z; Fayad R; Paus R; Bulfone-Paus S
    J Biol Chem; 2003 Jan; 278(3):1549-60. PubMed ID: 12424250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity.
    Bode JG; Gatsios P; Ludwig S; Rapp UR; Häussinger D; Heinrich PC; Graeve L
    J Biol Chem; 1999 Oct; 274(42):30222-7. PubMed ID: 10514514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation.
    Marie-Cardine A; Kirchgessner H; Bruyns E; Shevchenko A; Mann M; Autschbach F; Ratnofsky S; Meuer S; Schraven B
    J Exp Med; 1999 Apr; 189(8):1181-94. PubMed ID: 10209036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.
    Wang PY; Liu P; Weng J; Sontag E; Anderson RG
    EMBO J; 2003 Jun; 22(11):2658-67. PubMed ID: 12773382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity.
    Muda M; Theodosiou A; Gillieron C; Smith A; Chabert C; Camps M; Boschert U; Rodrigues N; Davies K; Ashworth A; Arkinstall S
    J Biol Chem; 1998 Apr; 273(15):9323-9. PubMed ID: 9535927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
    Todd JL; Rigas JD; Rafty LA; Denu JM
    Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
    Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.
    Bedecs K; Elbaz N; Sutren M; Masson M; Susini C; Strosberg AD; Nahmias C
    Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):449-54. PubMed ID: 9230127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.
    Muñoz JJ; Tárrega C; Blanco-Aparicio C; Pulido R
    Biochem J; 2003 May; 372(Pt 1):193-201. PubMed ID: 12583813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.
    Blanco-Aparicio C; Torres J; Pulido R
    J Cell Biol; 1999 Dec; 147(6):1129-36. PubMed ID: 10601328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine phosphorylation of VHR phosphatase by ZAP-70.
    Alonso A; Rahmouni S; Williams S; van Stipdonk M; Jaroszewski L; Godzik A; Abraham RT; Schoenberger SP; Mustelin T
    Nat Immunol; 2003 Jan; 4(1):44-8. PubMed ID: 12447358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W; Pew T; Zou M; Pang D; Conzen SD
    J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
    Franklin CC; Kraft AS
    J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.